Evaluating Dentsply Sirona: Insights From 8 Financial Analysts

Loading...
Loading...

Dentsply Sirona XRAY has been analyzed by 8 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.

The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.

Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
Total Ratings 2 3 3 0 0
Last 30D 1 0 0 0 0
1M Ago 0 0 0 0 0
2M Ago 1 0 1 0 0
3M Ago 0 3 2 0 0

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $37.88, along with a high estimate of $43.00 and a low estimate of $32.00. Observing a downward trend, the current average is 9.81% lower than the prior average price target of $42.00.

Understanding Analyst Ratings: A Comprehensive Breakdown

An in-depth analysis of recent analyst actions unveils how financial experts perceive Dentsply Sirona. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target
David Saxon Needham Raises Buy $42.00 $35.00
David Saxon Needham Announces Buy $35.00 -
Jonathan Block Stifel Lowers Hold $32.00 $35.00
Nathan Rich Goldman Sachs Lowers Neutral $36.00 $42.00
Michael Petusky Barrington Research Lowers Outperform $41.00 $51.00
Erin Wright Morgan Stanley Lowers Overweight $39.00 $43.00
Jonathan Block Stifel Lowers Hold $35.00 $41.00
Erin Wright Morgan Stanley Lowers Overweight $43.00 $47.00

Key Insights:

Loading...
Loading...
  • Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Dentsply Sirona. This offers insight into analysts' perspectives on the current state of the company.
  • Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Dentsply Sirona compared to the broader market.
  • Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Dentsply Sirona's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.

Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Dentsply Sirona's market position. Stay informed and make well-informed decisions with our Ratings Table.

Stay up to date on Dentsply Sirona analyst ratings.

All You Need to Know About Dentsply Sirona

Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (manufactured dental consumables and lab products) and Sirona Dental Systems (manufactured technologically-advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology and equipment through third-party distributors and the remaining portfolio is either sold to labs and offices through the firm's salesforce or directly to consumers (such as Byte clear aligner).

Dentsply Sirona's Economic Impact: An Analysis

Market Capitalization Analysis: The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.

Revenue Challenges: Dentsply Sirona's revenue growth over 3 months faced difficulties. As of 30 September, 2023, the company experienced a decline of approximately 0.0%. This indicates a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Health Care sector.

Net Margin: Dentsply Sirona's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of -28.09%, the company may face hurdles in effective cost management.

Return on Equity (ROE): Dentsply Sirona's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of -7.51%, the company may encounter challenges in delivering satisfactory returns for shareholders.

Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of -3.58%, the company may need to address challenges in generating satisfactory returns from its assets.

Debt Management: Dentsply Sirona's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.63.

The Basics of Analyst Ratings

Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter.

Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
date
▲▼
ticker
▲▼
name
▲▼
Price Target
▲▼
Upside/Downside
▲▼
Recommendation
▲▼
Firm
▲▼
Posted In: Analyst RatingsBZI-AAR
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...